Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in chronic chikungunya arthritis
NCT04483466Phase 3Active, not recruiting
- Sponsor
- George Washington University
- Start
- Jul 2023
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in chikungunya arthritis, sponsored by George Washington University. Started Jul 2023; status: active, not recruiting.
02
Drugs
methotrexate
03
Conditions
chikungunya arthritis
Beyond the preview
Go deeper on NCT04483466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04483466.